Latest revenue
$496.2M
as of 2026-03-31
Latest net income
$-26.6M
as of 2026-03-31
Net margin
-5.4%
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Services-Management Services (6 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Community sentiment
Where do you think EVH is heading?
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $474.1M
- Enterprise value
- $1.31B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- 1.20×
- Dividend yield
- 0.0%
- 52-wk high
- $12.06
- 52-wk low
- $2.10
- Beta
- —
- Shares out
- 112.5M
5-year trend
What this company does
Item 1. Business Market Opportunity Evolent is a market leader in connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. We work on behalf of health plans and other risk-bearing entities and payers (our customers) to support physicians and other healthcare providers (our users) in providing high quality evidence-based care to their patients. We believe adherence to evidence-based clinical pathways supports better outcomes for patients, a better experience for physicians, and lower costs for the healthcare system overall. Specialty care represents a significant and fast-growing portion of healthcare costs in the United States,…
AI summary unavailable — showing raw filing excerpt
Generated from EVH's filing dated 2026-02-25
Key risks
Item 1A. Risk Factors The following summary highlights some of the principal risks that could adversely affect our business, financial condition or results of operations. This summary is not complete and the risks summarized below are not the only risks we face. These risks are discussed more fully further below. These risks include, but are not limited to, the following: •the significant portion of revenue we derive from our largest partners, and the potential loss, termination or renegotiation of our relationship or contract with any significant partner, or multiple partners in the aggregate; •the increasing number of risk-sharing arrangements we enter into with our partners; •the growth…
AI summary unavailable — showing raw filing excerpt
Generated from EVH's filing dated 2026-02-25
Profitability
Operating margin
-21.9%
1279.4%Net margin
-28.5%
1081.1%Return on equity
-128.7%
2130.5%Return on assets
-28.1%
1062.0%Leverage
Debt / equity
3.57×
158.4%Long-term debt / equity
2.34×
408.8%Debt / assets
78.1%
34.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $496.2M | +2.6% | $-26.6M | +58.8% | -5.4% |
Q4 2025 2025-12-31 | $468.7M | -27.5% | $-429.1M | -1782.0% | -91.6% |
Q3 2025 2025-09-30 | $479.5M | -22.8% | $-20.9M | +9.8% | -4.4% |
Q2 2025 2025-06-30 | $444.3M | -31.3% | $-19.9M | -1346.7% | -4.5% |
Q1 2025 2025-03-31 | $483.6M | -24.4% | $-64.6M | -273.9% | -13.4% |
Q4 2024 2024-12-31 | $646.5M | — | $-22.8M | — | -3.5% |
Q3 2024 2024-09-30 | $621.4M | +21.6% | $-23.1M | +8.6% | -3.7% |
Q2 2024 2024-06-30 | $647.1M | +37.9% | $1.6M | +104.6% | 0.2% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Management Services · SIC 8741
Your notes
Keep private notes on EVH — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$38.2K
Insider selling
$0
Net activity
+$38.2K
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns EVH
Institutional value
$93.9M
Total shares held
41.6M
Distinct holders
102
-113 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.9M | $24.8M | +557.3K (+5.4%) | Added |
| 2 | UBS Group AG | 8.2M | $18.6M | +2.0M (+33.4%) | Added |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | $11.1M | — | New |
| 4 | Tejara Capital Ltd | 1.9M | $4.4M | +615.2K (+46.2%) | Added |
| 5 | JANE STREET GROUP, LLC | 1.8M | $4.1M | -1.2M (-39.4%) | Trimmed |
| 6 | DIMENSIONAL FUND ADVISORS LP | 1.8M | $4.1M | -517.5K (-22.4%) | Trimmed |
| 7 | KENNEDY CAPITAL MANAGEMENT LLC | 1.6M | $3.6M | +672.0K (+72.6%) | Added |
| 8 | Hudson Bay Capital Management LP | 1.3M | $3.0M | -143.6K (-9.8%) | Trimmed |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 930.9K | $2.1M | — | New |
| 10 | BNP PARIBAS FINANCIAL MARKETS | 891.4K | $2.0M | +347.0K (+63.7%) | Added |
| 11 | CITIGROUP INC | 812.1K | $1.9M | +227.6K (+38.9%) | Added |
| 12 | VANGUARD FIDUCIARY TRUST CO | 727.9K | $1.7M | — | New |
| 13 | Invesco Ltd. | 443.9K | $1.0M | +51.6K (+13.2%) | Added |
| 14 | JPMORGAN CHASE & CO | 390.5K | $847.3K | -2.6M (-86.8%) | Trimmed |
| 15 | Creative Planning | 347.4K | $792.0K | +181.2K (+109.0%) | Added |
| 16 | Bank of New York Mellon Corp | 328.5K | $749.1K | -18.6K (-5.4%) | Trimmed |
| 17 | SEI INVESTMENTS CO | 302.3K | $689.2K | +101.9K (+50.8%) | Added |
| 18 | Jefferies Financial Group Inc. | 291.6K | $664.8K | +0 (+0.0%) | No change |
| 19 | Walleye Capital LLC | 271.9K | $619.9K | +133.2K (+96.0%) | Added |
| 20 | Quantbot Technologies LP | 270.5K | $616.8K | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once EVH's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.